MiR-33a suppresses breast cancer cell proliferation and metastasis by targeting ADAM9 and ROS1

Choroidal metastasis response to crizotinib in a ROS1-rearranged NSCLC patient

(2015) Stephanie Lu et al.   LUNG CANCER

The past, present and future of breast cancer research in China

(2014) Wei Hong et al.   CANCER LETTERS

miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways

(2014) Hui Wang et al.   JOURNAL OF CLINICAL INVESTIGATION

miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST

(2014) Yong Zhou et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer

(2014) Alice T. Shaw et al.   NEW ENGLAND JOURNAL OF MEDICINE

ADAM9 silencing inhibits breast tumor cell invasion in vitro

(2013) Kelli Cristina Micocci et al.   BIOCHIMIE

Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24

(2013) Allan Yi Liu et al.   CARCINOGENESIS

Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells

(2013) Zhuo-Jian Li et al.   CELLULAR SIGNALLING

Tumor metastasis: moving new biological insights into the clinic

(2013) Liling Wan et al.   NATURE MEDICINE

Periostin: A Bridge between Cancer Stem Cells and Their Metastatic Niche

(2012) Zhe Wang et al.   Cell Stem Cell

ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers

(2012) Kristin Bergethon et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA

(2012) S. Volinia et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MicroRNA Replacement Therapy for miR-145 and miR-33a Is Efficacious in a Model of Colon Carcinoma

(2011) A. F. Ibrahim et al.   CANCER RESEARCH

Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides

(2011) Katey J. Rayner et al.   NATURE

Twist2 contributes to breast cancer progression by promoting an epithelial–mesenchymal transition and cancer stem-like cell self-renewal

(2011) X Fang et al.   ONCOGENE

The proto-oncogene Pim-1 is a target of miR-33a

(2011) M Thomas et al.   ONCOGENE

A Perspective on Cancer Cell Metastasis

(2011) C. L. Chaffer et al.   SCIENCE

miR-33 links SREBP-2 induction to repression of sterol transporters

(2010) T. J. Marquart et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis

(2010) S. H. Najafi-Shoushtari et al.   SCIENCE

MiR-33 Contributes to the Regulation of Cholesterol Homeostasis

(2010) K. J. Rayner et al.   SCIENCE

MicroRNAs: Novel regulators in the hallmarks of human cancer

(2009) Kai Ruan et al.   CANCER LETTERS

Emerging roles of ADAM and ADAMTS metalloproteinases in cancer

(2007) N. Rocks et al.   BIOCHIMIE